- Prolactinoma presenting as giant cystic pituitary mass
-
Kim MK, Shin JY, Lim DJ, Baek KH, Kang MI, Lee KW
- KMID: 2256514
- Korean J Med.
- 2006 Dec;71(6):699-700.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of prolactinoma with chief complaint of male infertility
-
Song YS, Kim SJ, Lee MS
- KMID: 1960411
- J Korean Androl Soc.
- 1991 Jun;9(1):55-58.
The main symptoms of prolactinoma in men are due to tumor mass effect such as headache, visual field defect and impairment of pituitary secretory capacity. Hyperprolacinemic symptoms also may be... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical approach of Hyperprolactinemia
-
Jeong IK
- KMID: 2081292
- Korean J Med.
- 2007 Jun;72(6):698-701.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pituitary Macroadenoma Concurrently Diagnosed in a Patient Undergoing Antipsychotic Treatment
-
Kim BS, Kim JS, Ryu HK, Park JW, Hyun SA, Kang JW, Choi YJ
- KMID: 2269175
- Korean J Med.
- 2015 Jan;88(1):78-82.
- doi: 10.3904/kjm.2015.88.1.78
Antipsychotics are the drug of choice for patients with schizophrenia, but they can induce hyperprolactinemia and growth of pituitary adenomas by blocking dopamine 2 receptors in the pituitary gland. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Macroprolactinoma in a young man presenting with erectile dysfunction
-
Song SH, Lee J, Kim DS
- KMID: 2469597
- Clin Exp Reprod Med.
- 2019 Dec;46(4):202-205.
- doi: 10.5653/cerm.2019.00339
Hyperprolactinemia due to a pituitary adenoma is a rare cause of erectile dysfunction (ED). The prevalence of clinically apparent prolactinomas is reported to be from 6–10 to 50 per 100,000.... -
- CITED
-
- Close
- SHARE
-
- Close
- Update in Prolactinomas
-
Hong JW, Lee EJ
- KMID: 2168209
- Hanyang Med Rev.
- 2012 Nov;32(4):192-196.
- doi: 10.7599/hmr.2012.32.4.192
Prolactinomas are frequent causes of gonadal dysfunction and infertility. Dopamine agonists are the main treatment of prolactinoma and the excellent efficacy of the dopamine agonist is well known. Current challenges... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
-
Huang J, Zhang F, Jiang L, Hu G, Sun W, Zhang C, Ding X
- KMID: 2378108
- Cancer Res Treat.
- 2017 Apr;49(2):358-373.
- doi: 10.4143/crt.2016.017
PURPOSE: Prolactinoma (prolactin-secreting pituitary adenoma) is one of the most common estrogen-related functional pituitary tumors. As an agonist of the dopamine D2 receptor, bromocriptine is used widely to inhibit prolactinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Multiple Endocrine Neoplasia Type 1 Presenting with an Invasive Giant Prolactinoma
-
Cha J, Kim JS, Han JS, Park YW, Kim MJ, Ku YH, Kim HI
- KMID: 2361438
- Korean J Med.
- 2016 Dec;91(3):300-305.
- doi: 10.3904/kjm.2016.91.3.300
Pituitary tumors occur in 15-50% of patients with multiple endocrine neoplasia of type 1 (MEN1). To the best of our knowledge, no MEN1 case in which the initial lesion was... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
-
Cho EH, Lee SA, Chung JY, Koh EH, Cho YH, Kim JH, Kim CJ, Kim MS
- KMID: 1782009
- J Korean Med Sci.
- 2009 Oct;24(5):874-878.
- doi: 10.3346/jkms.2009.24.5.874
Although cabergoline is effective in the treatment of micro- and macro-prolactinoma, little is known about its efficacy in the treatment of invasive giant prolactinoma. We investigated the efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Characteristics of Macroprolactinemia
-
Choi YJ, Kang JG, Kim SY, Hong ES, Kim SW, Shin CS, Kim SY, Cho BY, Lee HK
- KMID: 2200560
- J Korean Soc Endocrinol.
- 2005 Jun;20(3):216-223.
- doi: 10.3803/jkes.2005.20.3.216
BACKGROUND: Prolactin has been identified by gel chromatography to exist is three different forms in human serum; monomeric prolactin(molecular mass 23kDa), big prolactin (molecular mass 50~60 kDa) and big big... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Endocrinologic Differences between Prolactinoma and Pseudoprolactinoma Proven by Immunohistochemical Study
-
Jo JW, Lee EJ, Nam MS, Nam SY, Song YD, Lee HC, Huh KB, Kim TS, Kim SH, Kim KR, Cha BS, Lee JH, Lim SK
- KMID: 2462170
- J Korean Soc Endocrinol.
- 1995 Dec;10(4):362-369.
Hyperprolactinemia is the most common hypothalamo-pituitary disorder encountered in clinical endocrinology. Excluding the drug-induced hyperprolactinemia, the most common cause of this disorder is a pituitary tumor. Prolactinoma is mainly made... -
- CITED
-
- Close
- SHARE
-
- Close
- Prolactinoma: Surgical Treatment and Outcome
-
Kwon TH, Chung YG, Cho TH, Park JY, Park YK, Chung HS, Lee KC, Lee HK
- KMID: 2019037
- J Korean Neurosurg Soc.
- 1998 Mar;27(3):357-362.
Thirty-seven patients with prolactinoma treated over a seven-year period were retrospectively reviewed. During the same period, a total of 104 patients with pituitary adenoma were treated at our hospital, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Surgical Results of Pituitary Adenomas
-
Kim JH, Kim CJ, Kwon Y, Rhim SC, Lee JK, Kwun BD, Whang CJ
- KMID: 1955156
- J Korean Neurosurg Soc.
- 1995 Apr;24(4):383-394.
From June, 1989 to December, 1993, 162 patients were diagnosed as a pituitary adenoma and treated by a surgical procedure. These patients were analyzed in terms of preoperative and postoperative... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Analysis of Functiononing Pituitary Adenoma
-
Park K, Choi KS, Kim HJ, Kim CS
- KMID: 2019730
- J Korean Neurosurg Soc.
- 1982 Dec;11(4):533-542.
Forty-four patients were operated on functioning pituitary adenomas during 5 years since Jun. 1977 at the Department of Neurosurgery, Seoul National University Hospital. Clinical and laboratory findings were analyzed and... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Outcome of Pituitary Prolactinomas
-
Jung TY, Kim JH, Kim IY, Kim TS, Jung S, Kim SH
- KMID: 1904620
- J Korean Neurosurg Soc.
- 2002 Oct;32(4):307-311.
OBJECTIVE: The purpose of this study is to analyse the surgical outcome of prolactinoma and to evaluate the treatment modality. METHODS: Author has reviewed retrospectively the results of transsphenoidal microsurgical management... -
- CITED
-
- Close
- SHARE
-
- Close
- An Epidemiologic Study on Pituitary Diseas
-
Lee YS, Shin HH, Cho DH, Lee DB, Kim YJ, Park JH, Lee DH, Chung DJ, Chung MY, Lee TH
- KMID: 2048573
- Chonnam Med J.
- 1998 Dec;34(2):297-308.
Hypopituitarism can be casused by various disease. The present study was performed on Korean patients with hypopituitarism and functional pituitary adenoma, who were examined from 1988 to 1997. One hundred... -
- CITED
-
- Close
- SHARE
-
- Close
- Normal Repetitive Pregnancies and Tumor Regression Induced by Low-Dose Bromocriptine in a Patient with Macroprolactinoma
-
Choi HJ, Park JY, Choi WS, Song JG, Kim HY, Seo JA, Kim SG, Kim NH, Choi KM, Baik SH, Choi DS
- KMID: 1468495
- J Korean Endocr Soc.
- 2009 Mar;24(1):42-46.
- doi: 10.3803/jkes.2009.24.1.42
Prolactin-secreting adenomas are the most common pituitary tumors. Menstrual disturbances and infertility are the main complaints in women with prolactinoma. Dopaminergic agonists such as bromocriptine are well-established treatments for prolactinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bromocriptine Treatment for Invasive Prolactinoma
-
Yang MS, Kim SH, Lim SG, Lee SK
- KMID: 1956355
- J Korean Neurosurg Soc.
- 2005 Apr;37(4):275-281.
OBJECTIVE: The prolactinoma is the most common pituitary tumor and sometimes shows severe invasiveness to the adjacent cavernous sinus, especially in the male patient. The dopamine agonist can be used... -
- CITED
-
- Close
- SHARE
-
- Close
- Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
-
Cho KR, Jo KI, Shin HJ
- KMID: 2048478
- Brain Tumor Res Treat.
- 2013 Oct;1(2):71-77.
- doi: 10.14791/btrt.2013.1.2.71
OBJECTIVE: The objective of this study was to describe and characterize the clinical course of treatment for invasive prolactinoma patients using bromocriptine. METHODS: The study group included 23 patients who were... -
- CITED
-
- Close
- SHARE
-
- Close
- High Dose Hook Effect in Macroprolactinoma
-
Kim MS
- KMID: 2331190
- J Korean Soc Endocrinol.
- 2005 Apr;20(2):118-119.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
